Global Amyotrophic Lateral Sclerosis Treatment Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.
The global Amyotrophic Lateral Sclerosis Treatment market size is projected to grow from US$ 293.5 million in 2023 to US$ 373.6 million in 2030; it is expected to grow at a CAGR of 3.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Amyotrophic Lateral Sclerosis Treatment Industry Forecast” looks at past sales and reviews total world Amyotrophic Lateral Sclerosis Treatment sales in 2023, providing a comprehensive analysis by region and market sector of projected Amyotrophic Lateral Sclerosis Treatment sales for 2024 through 2030. With Amyotrophic Lateral Sclerosis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amyotrophic Lateral Sclerosis Treatment industry.
This Insight Report provides a comprehensive analysis of the global Amyotrophic Lateral Sclerosis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amyotrophic Lateral Sclerosis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amyotrophic Lateral Sclerosis Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amyotrophic Lateral Sclerosis Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amyotrophic Lateral Sclerosis Treatment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Amyotrophic Lateral Sclerosis Treatment market by product type, application, key players and key regions and countries.
Segmentation by type
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.
The global Amyotrophic Lateral Sclerosis Treatment market size is projected to grow from US$ 293.5 million in 2023 to US$ 373.6 million in 2030; it is expected to grow at a CAGR of 3.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Amyotrophic Lateral Sclerosis Treatment Industry Forecast” looks at past sales and reviews total world Amyotrophic Lateral Sclerosis Treatment sales in 2023, providing a comprehensive analysis by region and market sector of projected Amyotrophic Lateral Sclerosis Treatment sales for 2024 through 2030. With Amyotrophic Lateral Sclerosis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amyotrophic Lateral Sclerosis Treatment industry.
This Insight Report provides a comprehensive analysis of the global Amyotrophic Lateral Sclerosis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amyotrophic Lateral Sclerosis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amyotrophic Lateral Sclerosis Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amyotrophic Lateral Sclerosis Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amyotrophic Lateral Sclerosis Treatment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Amyotrophic Lateral Sclerosis Treatment market by product type, application, key players and key regions and countries.
Segmentation by type
- Medication
- Physical Therapy
- Speech Therapy
- Others
- Hospitals
- Specialty Centers
- Research Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Roche
- Biogen
- Mitsubishi Tanabe Pharma
- GNT Pharma
- Synthetic Biologics
- Amkor Pharma
- ViroMed
- Brainstorm Therapeutics
- Bausch Health
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amyotrophic Lateral Sclerosis Treatment Market Size 2019-2030
2.1.2 Amyotrophic Lateral Sclerosis Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Amyotrophic Lateral Sclerosis Treatment Segment by Type
2.2.1 Medication
2.2.2 Physical Therapy
2.2.3 Speech Therapy
2.2.4 Others
2.3 Amyotrophic Lateral Sclerosis Treatment Market Size by Type
2.3.1 Amyotrophic Lateral Sclerosis Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
2.4 Amyotrophic Lateral Sclerosis Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Centers
2.4.3 Research Centers
2.4.4 Others
2.5 Amyotrophic Lateral Sclerosis Treatment Market Size by Application
2.5.1 Amyotrophic Lateral Sclerosis Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
3 AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE BY PLAYER
3.1 Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Players
3.1.1 Global Amyotrophic Lateral Sclerosis Treatment Revenue by Players (2019-2024)
3.1.2 Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Amyotrophic Lateral Sclerosis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AMYOTROPHIC LATERAL SCLEROSIS TREATMENT BY REGIONS
4.1 Amyotrophic Lateral Sclerosis Treatment Market Size by Regions (2019-2024)
4.2 Americas Amyotrophic Lateral Sclerosis Treatment Market Size Growth (2019-2024)
4.3 APAC Amyotrophic Lateral Sclerosis Treatment Market Size Growth (2019-2024)
4.4 Europe Amyotrophic Lateral Sclerosis Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2019-2024)
5.2 Americas Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024)
5.3 Americas Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amyotrophic Lateral Sclerosis Treatment Market Size by Region (2019-2024)
6.2 APAC Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024)
6.3 APAC Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Amyotrophic Lateral Sclerosis Treatment by Country (2019-2024)
7.2 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024)
7.3 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment by Region (2019-2024)
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET FORECAST
10.1 Global Amyotrophic Lateral Sclerosis Treatment Forecast by Regions (2025-2030)
10.1.1 Global Amyotrophic Lateral Sclerosis Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Amyotrophic Lateral Sclerosis Treatment Forecast
10.1.3 APAC Amyotrophic Lateral Sclerosis Treatment Forecast
10.1.4 Europe Amyotrophic Lateral Sclerosis Treatment Forecast
10.1.5 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Forecast
10.2 Americas Amyotrophic Lateral Sclerosis Treatment Forecast by Country (2025-2030)
10.2.1 United States Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.2.2 Canada Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.2.3 Mexico Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.2.4 Brazil Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.3 APAC Amyotrophic Lateral Sclerosis Treatment Forecast by Region (2025-2030)
10.3.1 China Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.3.2 Japan Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.3.3 Korea Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.3.4 Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.3.5 India Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.3.6 Australia Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.4 Europe Amyotrophic Lateral Sclerosis Treatment Forecast by Country (2025-2030)
10.4.1 Germany Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.4.2 France Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.4.3 UK Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.4.4 Italy Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.4.5 Russia Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.5 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.5.2 South Africa Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.5.3 Israel Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.5.4 Turkey Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.5.5 GCC Countries Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.6 Global Amyotrophic Lateral Sclerosis Treatment Forecast by Type (2025-2030)
10.7 Global Amyotrophic Lateral Sclerosis Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Amyotrophic Lateral Sclerosis Treatment Product Offered
11.1.3 Sanofi Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Amyotrophic Lateral Sclerosis Treatment Product Offered
11.2.3 Roche Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Biogen
11.3.1 Biogen Company Information
11.3.2 Biogen Amyotrophic Lateral Sclerosis Treatment Product Offered
11.3.3 Biogen Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Biogen Main Business Overview
11.3.5 Biogen Latest Developments
11.4 Mitsubishi Tanabe Pharma
11.4.1 Mitsubishi Tanabe Pharma Company Information
11.4.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Product Offered
11.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Mitsubishi Tanabe Pharma Main Business Overview
11.4.5 Mitsubishi Tanabe Pharma Latest Developments
11.5 GNT Pharma
11.5.1 GNT Pharma Company Information
11.5.2 GNT Pharma Amyotrophic Lateral Sclerosis Treatment Product Offered
11.5.3 GNT Pharma Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GNT Pharma Main Business Overview
11.5.5 GNT Pharma Latest Developments
11.6 Synthetic Biologics
11.6.1 Synthetic Biologics Company Information
11.6.2 Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Product Offered
11.6.3 Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Synthetic Biologics Main Business Overview
11.6.5 Synthetic Biologics Latest Developments
11.7 Amkor Pharma
11.7.1 Amkor Pharma Company Information
11.7.2 Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Product Offered
11.7.3 Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Amkor Pharma Main Business Overview
11.7.5 Amkor Pharma Latest Developments
11.8 ViroMed
11.8.1 ViroMed Company Information
11.8.2 ViroMed Amyotrophic Lateral Sclerosis Treatment Product Offered
11.8.3 ViroMed Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ViroMed Main Business Overview
11.8.5 ViroMed Latest Developments
11.9 Brainstorm Therapeutics
11.9.1 Brainstorm Therapeutics Company Information
11.9.2 Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Product Offered
11.9.3 Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Brainstorm Therapeutics Main Business Overview
11.9.5 Brainstorm Therapeutics Latest Developments
11.10 Bausch Health
11.10.1 Bausch Health Company Information
11.10.2 Bausch Health Amyotrophic Lateral Sclerosis Treatment Product Offered
11.10.3 Bausch Health Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Bausch Health Main Business Overview
11.10.5 Bausch Health Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amyotrophic Lateral Sclerosis Treatment Market Size 2019-2030
2.1.2 Amyotrophic Lateral Sclerosis Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Amyotrophic Lateral Sclerosis Treatment Segment by Type
2.2.1 Medication
2.2.2 Physical Therapy
2.2.3 Speech Therapy
2.2.4 Others
2.3 Amyotrophic Lateral Sclerosis Treatment Market Size by Type
2.3.1 Amyotrophic Lateral Sclerosis Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
2.4 Amyotrophic Lateral Sclerosis Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Centers
2.4.3 Research Centers
2.4.4 Others
2.5 Amyotrophic Lateral Sclerosis Treatment Market Size by Application
2.5.1 Amyotrophic Lateral Sclerosis Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
3 AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE BY PLAYER
3.1 Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Players
3.1.1 Global Amyotrophic Lateral Sclerosis Treatment Revenue by Players (2019-2024)
3.1.2 Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Amyotrophic Lateral Sclerosis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AMYOTROPHIC LATERAL SCLEROSIS TREATMENT BY REGIONS
4.1 Amyotrophic Lateral Sclerosis Treatment Market Size by Regions (2019-2024)
4.2 Americas Amyotrophic Lateral Sclerosis Treatment Market Size Growth (2019-2024)
4.3 APAC Amyotrophic Lateral Sclerosis Treatment Market Size Growth (2019-2024)
4.4 Europe Amyotrophic Lateral Sclerosis Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2019-2024)
5.2 Americas Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024)
5.3 Americas Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amyotrophic Lateral Sclerosis Treatment Market Size by Region (2019-2024)
6.2 APAC Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024)
6.3 APAC Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Amyotrophic Lateral Sclerosis Treatment by Country (2019-2024)
7.2 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024)
7.3 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment by Region (2019-2024)
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET FORECAST
10.1 Global Amyotrophic Lateral Sclerosis Treatment Forecast by Regions (2025-2030)
10.1.1 Global Amyotrophic Lateral Sclerosis Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Amyotrophic Lateral Sclerosis Treatment Forecast
10.1.3 APAC Amyotrophic Lateral Sclerosis Treatment Forecast
10.1.4 Europe Amyotrophic Lateral Sclerosis Treatment Forecast
10.1.5 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Forecast
10.2 Americas Amyotrophic Lateral Sclerosis Treatment Forecast by Country (2025-2030)
10.2.1 United States Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.2.2 Canada Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.2.3 Mexico Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.2.4 Brazil Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.3 APAC Amyotrophic Lateral Sclerosis Treatment Forecast by Region (2025-2030)
10.3.1 China Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.3.2 Japan Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.3.3 Korea Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.3.4 Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.3.5 India Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.3.6 Australia Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.4 Europe Amyotrophic Lateral Sclerosis Treatment Forecast by Country (2025-2030)
10.4.1 Germany Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.4.2 France Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.4.3 UK Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.4.4 Italy Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.4.5 Russia Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.5 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.5.2 South Africa Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.5.3 Israel Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.5.4 Turkey Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.5.5 GCC Countries Amyotrophic Lateral Sclerosis Treatment Market Forecast
10.6 Global Amyotrophic Lateral Sclerosis Treatment Forecast by Type (2025-2030)
10.7 Global Amyotrophic Lateral Sclerosis Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Amyotrophic Lateral Sclerosis Treatment Product Offered
11.1.3 Sanofi Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Amyotrophic Lateral Sclerosis Treatment Product Offered
11.2.3 Roche Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Biogen
11.3.1 Biogen Company Information
11.3.2 Biogen Amyotrophic Lateral Sclerosis Treatment Product Offered
11.3.3 Biogen Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Biogen Main Business Overview
11.3.5 Biogen Latest Developments
11.4 Mitsubishi Tanabe Pharma
11.4.1 Mitsubishi Tanabe Pharma Company Information
11.4.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Product Offered
11.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Mitsubishi Tanabe Pharma Main Business Overview
11.4.5 Mitsubishi Tanabe Pharma Latest Developments
11.5 GNT Pharma
11.5.1 GNT Pharma Company Information
11.5.2 GNT Pharma Amyotrophic Lateral Sclerosis Treatment Product Offered
11.5.3 GNT Pharma Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GNT Pharma Main Business Overview
11.5.5 GNT Pharma Latest Developments
11.6 Synthetic Biologics
11.6.1 Synthetic Biologics Company Information
11.6.2 Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Product Offered
11.6.3 Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Synthetic Biologics Main Business Overview
11.6.5 Synthetic Biologics Latest Developments
11.7 Amkor Pharma
11.7.1 Amkor Pharma Company Information
11.7.2 Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Product Offered
11.7.3 Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Amkor Pharma Main Business Overview
11.7.5 Amkor Pharma Latest Developments
11.8 ViroMed
11.8.1 ViroMed Company Information
11.8.2 ViroMed Amyotrophic Lateral Sclerosis Treatment Product Offered
11.8.3 ViroMed Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ViroMed Main Business Overview
11.8.5 ViroMed Latest Developments
11.9 Brainstorm Therapeutics
11.9.1 Brainstorm Therapeutics Company Information
11.9.2 Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Product Offered
11.9.3 Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Brainstorm Therapeutics Main Business Overview
11.9.5 Brainstorm Therapeutics Latest Developments
11.10 Bausch Health
11.10.1 Bausch Health Company Information
11.10.2 Bausch Health Amyotrophic Lateral Sclerosis Treatment Product Offered
11.10.3 Bausch Health Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Bausch Health Main Business Overview
11.10.5 Bausch Health Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Amyotrophic Lateral Sclerosis Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Medication
Table 3. Major Players of Physical Therapy
Table 4. Major Players of Speech Therapy
Table 5. Major Players of Others
Table 6. Amyotrophic Lateral Sclerosis Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Table 9. Amyotrophic Lateral Sclerosis Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Table 12. Global Amyotrophic Lateral Sclerosis Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Player (2019-2024)
Table 14. Amyotrophic Lateral Sclerosis Treatment Key Players Head office and Products Offered
Table 15. Amyotrophic Lateral Sclerosis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Amyotrophic Lateral Sclerosis Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Regions (2019-2024)
Table 20. Global Amyotrophic Lateral Sclerosis Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Country (2019-2024)
Table 24. Americas Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Table 26. Americas Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Table 28. APAC Amyotrophic Lateral Sclerosis Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Region (2019-2024)
Table 30. APAC Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Table 32. APAC Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Table 34. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Country (2019-2024)
Table 36. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Table 38. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Amyotrophic Lateral Sclerosis Treatment
Table 47. Key Market Challenges & Risks of Amyotrophic Lateral Sclerosis Treatment
Table 48. Key Industry Trends of Amyotrophic Lateral Sclerosis Treatment
Table 49. Global Amyotrophic Lateral Sclerosis Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Amyotrophic Lateral Sclerosis Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Amyotrophic Lateral Sclerosis Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Sanofi Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 54. Sanofi Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 55. Sanofi Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Sanofi Main Business
Table 57. Sanofi Latest Developments
Table 58. Roche Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 59. Roche Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 60. Roche Main Business
Table 61. Roche Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Roche Latest Developments
Table 63. Biogen Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 64. Biogen Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 65. Biogen Main Business
Table 66. Biogen Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Biogen Latest Developments
Table 68. Mitsubishi Tanabe Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 69. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 70. Mitsubishi Tanabe Pharma Main Business
Table 71. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Mitsubishi Tanabe Pharma Latest Developments
Table 73. GNT Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 74. GNT Pharma Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 75. GNT Pharma Main Business
Table 76. GNT Pharma Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. GNT Pharma Latest Developments
Table 78. Synthetic Biologics Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 79. Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 80. Synthetic Biologics Main Business
Table 81. Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Synthetic Biologics Latest Developments
Table 83. Amkor Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 84. Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 85. Amkor Pharma Main Business
Table 86. Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Amkor Pharma Latest Developments
Table 88. ViroMed Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 89. ViroMed Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 90. ViroMed Main Business
Table 91. ViroMed Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. ViroMed Latest Developments
Table 93. Brainstorm Therapeutics Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 94. Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 95. Brainstorm Therapeutics Main Business
Table 96. Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Brainstorm Therapeutics Latest Developments
Table 98. Bausch Health Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 99. Bausch Health Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 100. Bausch Health Main Business
Table 101. Bausch Health Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Bausch Health Latest Developments
Table 1. Amyotrophic Lateral Sclerosis Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Medication
Table 3. Major Players of Physical Therapy
Table 4. Major Players of Speech Therapy
Table 5. Major Players of Others
Table 6. Amyotrophic Lateral Sclerosis Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Table 9. Amyotrophic Lateral Sclerosis Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Table 12. Global Amyotrophic Lateral Sclerosis Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Player (2019-2024)
Table 14. Amyotrophic Lateral Sclerosis Treatment Key Players Head office and Products Offered
Table 15. Amyotrophic Lateral Sclerosis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Amyotrophic Lateral Sclerosis Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Regions (2019-2024)
Table 20. Global Amyotrophic Lateral Sclerosis Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Country (2019-2024)
Table 24. Americas Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Table 26. Americas Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Table 28. APAC Amyotrophic Lateral Sclerosis Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Region (2019-2024)
Table 30. APAC Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Table 32. APAC Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Table 34. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Country (2019-2024)
Table 36. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Table 38. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Amyotrophic Lateral Sclerosis Treatment
Table 47. Key Market Challenges & Risks of Amyotrophic Lateral Sclerosis Treatment
Table 48. Key Industry Trends of Amyotrophic Lateral Sclerosis Treatment
Table 49. Global Amyotrophic Lateral Sclerosis Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Amyotrophic Lateral Sclerosis Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Amyotrophic Lateral Sclerosis Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Sanofi Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 54. Sanofi Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 55. Sanofi Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Sanofi Main Business
Table 57. Sanofi Latest Developments
Table 58. Roche Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 59. Roche Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 60. Roche Main Business
Table 61. Roche Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Roche Latest Developments
Table 63. Biogen Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 64. Biogen Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 65. Biogen Main Business
Table 66. Biogen Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Biogen Latest Developments
Table 68. Mitsubishi Tanabe Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 69. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 70. Mitsubishi Tanabe Pharma Main Business
Table 71. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Mitsubishi Tanabe Pharma Latest Developments
Table 73. GNT Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 74. GNT Pharma Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 75. GNT Pharma Main Business
Table 76. GNT Pharma Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. GNT Pharma Latest Developments
Table 78. Synthetic Biologics Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 79. Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 80. Synthetic Biologics Main Business
Table 81. Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Synthetic Biologics Latest Developments
Table 83. Amkor Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 84. Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 85. Amkor Pharma Main Business
Table 86. Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Amkor Pharma Latest Developments
Table 88. ViroMed Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 89. ViroMed Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 90. ViroMed Main Business
Table 91. ViroMed Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. ViroMed Latest Developments
Table 93. Brainstorm Therapeutics Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 94. Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 95. Brainstorm Therapeutics Main Business
Table 96. Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Brainstorm Therapeutics Latest Developments
Table 98. Bausch Health Details, Company Type, Amyotrophic Lateral Sclerosis Treatment Area Served and Its Competitors
Table 99. Bausch Health Amyotrophic Lateral Sclerosis Treatment Product Offered
Table 100. Bausch Health Main Business
Table 101. Bausch Health Amyotrophic Lateral Sclerosis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Bausch Health Latest Developments
LIST OF FIGURES
Figure 1. Amyotrophic Lateral Sclerosis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Amyotrophic Lateral Sclerosis Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Amyotrophic Lateral Sclerosis Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Amyotrophic Lateral Sclerosis Treatment Sales Market Share by Country/Region (2023)
Figure 8. Amyotrophic Lateral Sclerosis Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type in 2023
Figure 10. Amyotrophic Lateral Sclerosis Treatment in Hospitals
Figure 11. Global Amyotrophic Lateral Sclerosis Treatment Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Amyotrophic Lateral Sclerosis Treatment in Specialty Centers
Figure 13. Global Amyotrophic Lateral Sclerosis Treatment Market: Specialty Centers (2019-2024) & ($ Millions)
Figure 14. Amyotrophic Lateral Sclerosis Treatment in Research Centers
Figure 15. Global Amyotrophic Lateral Sclerosis Treatment Market: Research Centers (2019-2024) & ($ Millions)
Figure 16. Amyotrophic Lateral Sclerosis Treatment in Others
Figure 17. Global Amyotrophic Lateral Sclerosis Treatment Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application in 2023
Figure 19. Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Player in 2023
Figure 20. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Amyotrophic Lateral Sclerosis Treatment Market Size 2019-2024 ($ Millions)
Figure 22. APAC Amyotrophic Lateral Sclerosis Treatment Market Size 2019-2024 ($ Millions)
Figure 23. Europe Amyotrophic Lateral Sclerosis Treatment Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size 2019-2024 ($ Millions)
Figure 25. Americas Amyotrophic Lateral Sclerosis Treatment Value Market Share by Country in 2023
Figure 26. United States Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Region in 2023
Figure 31. APAC Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type in 2023
Figure 32. APAC Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application in 2023
Figure 33. China Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Country in 2023
Figure 40. Europe Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Figure 41. Europe Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Figure 42. Germany Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 56. APAC Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 57. Europe Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 59. United States Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Canada Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 63. China Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Japan Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 65. Korea Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 67. India Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 68. Australia Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 69. Germany Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 70. France Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 71. UK Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Italy Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Russia Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 74. Spain Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 77. Israel Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 80. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Amyotrophic Lateral Sclerosis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Amyotrophic Lateral Sclerosis Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Amyotrophic Lateral Sclerosis Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Amyotrophic Lateral Sclerosis Treatment Sales Market Share by Country/Region (2023)
Figure 8. Amyotrophic Lateral Sclerosis Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type in 2023
Figure 10. Amyotrophic Lateral Sclerosis Treatment in Hospitals
Figure 11. Global Amyotrophic Lateral Sclerosis Treatment Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Amyotrophic Lateral Sclerosis Treatment in Specialty Centers
Figure 13. Global Amyotrophic Lateral Sclerosis Treatment Market: Specialty Centers (2019-2024) & ($ Millions)
Figure 14. Amyotrophic Lateral Sclerosis Treatment in Research Centers
Figure 15. Global Amyotrophic Lateral Sclerosis Treatment Market: Research Centers (2019-2024) & ($ Millions)
Figure 16. Amyotrophic Lateral Sclerosis Treatment in Others
Figure 17. Global Amyotrophic Lateral Sclerosis Treatment Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application in 2023
Figure 19. Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Player in 2023
Figure 20. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Amyotrophic Lateral Sclerosis Treatment Market Size 2019-2024 ($ Millions)
Figure 22. APAC Amyotrophic Lateral Sclerosis Treatment Market Size 2019-2024 ($ Millions)
Figure 23. Europe Amyotrophic Lateral Sclerosis Treatment Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size 2019-2024 ($ Millions)
Figure 25. Americas Amyotrophic Lateral Sclerosis Treatment Value Market Share by Country in 2023
Figure 26. United States Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Region in 2023
Figure 31. APAC Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type in 2023
Figure 32. APAC Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application in 2023
Figure 33. China Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Country in 2023
Figure 40. Europe Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Figure 41. Europe Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Figure 42. Germany Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Amyotrophic Lateral Sclerosis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 56. APAC Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 57. Europe Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 59. United States Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Canada Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 63. China Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Japan Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 65. Korea Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 67. India Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 68. Australia Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 69. Germany Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 70. France Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 71. UK Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Italy Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Russia Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 74. Spain Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 77. Israel Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Amyotrophic Lateral Sclerosis Treatment Market Size 2025-2030 ($ Millions)
Figure 80. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Amyotrophic Lateral Sclerosis Treatment Market Size Market Share Forecast by Application (2025-2030)
